Dissociation of vascular tolerance and plasma norepinephrine adjustment during long-term nitrate therapy in human coronary arteries

Intern Med. 1999 Oct;38(10):773-9. doi: 10.2169/internalmedicine.38.773.

Abstract

Objective: We examined whether changes in plasma norepinephrine (NE) concentration contribute to the development of nitrate tolerance in human coronary arteries.

Methods: Patients with stable angina were randomized to receiving nitrate (isosorbide dinitrate: ISDN or nitroglycerin: TNG) infusion for 30 minutes (group A), 48 hours (group B), or 78 hours (group C). Coronary diameters were measured angiographically at baseline (CT), during maximum dilation by ISDN (N1), at the end of nitrate infusion (N2) and after additional ISDN (1 mg) injection (N3).

Results: In groups A and B, N1, N2, and N3 were greater than CT, and there was no significant difference between N1, N2, and N3 for each group. In group C, N1 and N3 were greater than CT, but there was no difference between CT and N2, in the development of nitrate tolerance. In group A, NE increased significantly during nitrate infusion (304+/-163 vs. 418+/-273 pg/ml). NE did not change in groups B and C.

Conclusion: The change in NE concentration is not a primary contribution to the development of nitrate tolerance.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Angina Pectoris / blood
  • Angina Pectoris / drug therapy*
  • Coronary Angiography / methods
  • Coronary Vessels / drug effects*
  • Drug Tolerance
  • Female
  • Hemodynamics / drug effects
  • Humans
  • Isosorbide Dinitrate / administration & dosage
  • Isosorbide Dinitrate / therapeutic use*
  • Male
  • Middle Aged
  • Nitroglycerin / administration & dosage
  • Nitroglycerin / therapeutic use*
  • Norepinephrine / blood*
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Vasodilator Agents
  • Nitroglycerin
  • Isosorbide Dinitrate
  • Norepinephrine